CATEGORY : Biomarkers

Life Science Market Reports

Our life science market intelligence products have been recognized by market insiders and outsiders alike for their accuracy, in-depth analysis, and unique insights.

Market Reports

Pain Points, Unmet Needs, and Disruption in Precision Medicine – Part 1

DeciBio’s mission is to provide market intelligence and strategic insights that drive disruption and innovation in the precision medicine and life science industry. To this end, my colleague, Colin Enderlein,

The Future of the Clinical Microbiome: An Interview with Manoj Dadlani, CosmosID CEO

I spoke with Manoj Dadlani, the CEO of CosmosID, a sequencing and analytics company focused on helping pharmaceutical, public health, and academic collaborators understand and harness the microbiome. I took

ASHG 2019: DeciBio Highlights

We just returned from ASHG 2019 in Houston and while the city provided a lot of excitement with the Astro’s headed to the World Series, the meeting itself lacked any

Four Calls-to-Action for Digital Disrupters from #RHSUM19

Healthcare entrants, primarily startups and tech incumbents, came to the forefront of discussion at last week’s Rock Health Summit. As entrants emerge, healthcare is adapting to a proliferation of choice

An Updated Look at TMB: What Has Changed and What to Expect

Since we last reported on the rise of tumor mutational burden (TMB) in immuno-oncology (I/O) a year ago, there have been numerous material developments of this biomarker in the I/O

AACR 2019: DeciBio Highlights

A month ago, we attended AGBT 2019 and observed a strong interest in spatial profiling and single cell analysis. While we recognize that we are somewhat biased by the in-person

AGBT 2019: Spatial Profiling Among Many Growth Applications in Genomics

Highlights from the Advances in Genome Biology Technology 2019 General Meeting It was good to be back in Marco Island for #AGBT19, and to see that genomics continues to kill

Lessons Learned from the World’s First Gene-Edited Babies

Why enforceable regulation and greater inclusion and diversity in global discourse are critical to effective management of gene editing Earlier this week, He Jiankui, a professor at China’s Southern University

Three lessons for digital health entrepreneurs from #RHSUM18

This year’s Rock Health annual digital health summit showcased another impressive lineup, with speakers like Bernard Tyson (CEO of Kaiser Permanente), Toby Cosgrove (Executive Adviser for Google Cloud and former